series-c-plus
Stage
1
Investors
About
4D Molecular Therapeutics is a platform company that discovers and develops novel adeno-associated virus (AAV) vectors for use in gene therapy products. Its work is focused on creating AAV-based approaches to treat monogenic (single-gene) disorders.
Explore 4D Molecular Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.